AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation

por Maliandi, Maria Victoria, Mato-Berciano, Ana, Sobrevals, Luciano, Roué, Gaël, José, Anabel, Fillat, Cristina
Publicado 2015

A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel

por Mato-Berciano, Ana, Raimondi, Giulia, Maliandi, Maria Victoria, Alemany, Ramon, Montoliu, Lluis, Fillat, Cristina
Publicado 2017

Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems

por Fillat, Cristina, Jose, Anabel, Ros, Xavier Bofill-De, Mato-Berciano, Ana, Maliandi, Maria Victoria, Sobrevals, Luciano
Publicado 2011

Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation

por Farrera-Sal, Martí, Moreno, Rafael, Mato-Berciano, Ana, Maliandi, María Victoria, Bazan-Peregrino, Miriam, Alemany, Ramon
Publicado 2021

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

por Garcia-Carbonero, Rocio, Bazan-Peregrino, Miriam, Gil-Martín, Marta, Álvarez, Rafael, Macarulla, Teresa, Riesco-Martinez, Maria C, Verdaguer, Helena, Guillén-Ponce, Carmen, Farrera-Sal, Martí, Moreno, Rafael, Mato-Berciano, Ana, Maliandi, Maria Victoria, Torres-Manjon, Silvia, Costa, Marcel, del Pozo, Natalia, Martínez de Villarreal, Jaime, Real, Francisco X, Vidal, Noemí, Capella, Gabriel, Alemany, Ramon, Blasi, Emma, Blasco, Carmen, Cascalló, Manel, Salazar, Ramon
Publicado 2022